Agios Pharmaceuticals
AGIO
#5110
Rank
S$2.19 B
Marketcap
S$36.86
Share price
-0.55%
Change (1 day)
-16.56%
Change (1 year)

Market capitalization of Agios Pharmaceuticals (AGIO)

Market cap: S$2.19 Billion

As of June 2026 Agios Pharmaceuticals has a market cap of S$2.19 Billion. This makes Agios Pharmaceuticals the world's 5110th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Agios Pharmaceuticals from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026S$2.19 B4.48%
2025S$2.09 B-18.98%
2024S$2.58 B57.5%
2023S$1.64 B-20.52%
2022S$2.06 B-14.29%
2021S$2.41 B-39.21%
2020S$3.97 B-9.84%
2019S$4.40 B20.07%
2018S$3.66 B-1.63%
2017S$3.72 B46.91%
2016S$2.53 B-26.7%
2015S$3.46 B-36.97%
2014S$5.49 B480.1%
2013S$0.94 B

End of Day market cap according to different sources

On Jun 10th, 2026 the market cap of Agios Pharmaceuticals was reported to be:

S$2.20 Billion
by Nasdaq info icon info icon
S$2.20 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
S$191.40 B 8,632.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$1.328 T 60,511.95%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$136.02 B 6,105.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
S$1.15 B-47.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
S$17.25 B 687.31%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$13.77 B 528.50%๐Ÿ‡บ๐Ÿ‡ธ USA